NCT00002115View on ClinicalTrials.gov

A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Adefovir

Trial Locations (1)

98122

Univ of Washington, Seattle

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY

NCT00002115 - A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease. | Biotech Hunter | Biotech Hunter